Active, not recruiting
A Study of Galcanezumab (LY2951742) in Participants 12 to 17 Years of Age With Chronic Migraine
NCT04616326
- Conditions
- Chronic Migraine, Headache, Neurologic Manifestations, +3 more
- Locations
-
- Rehabilitation & Neurological Services Huntsville, Alabama, United States
- 21st Century Neurology, a Division of Xenoscience, Inc. Phoenix, Arizona, United States
- Phoenix Children's Hospital Phoenix, Arizona, United States
- Center for Neurosciences Tucson, Arizona, United States